The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market is segmented by Product (PTCA balloon, PTCA guide), Application (OEMs, Aftermarket), and Region (North America, Europe, Asia-Pacific, and the Rest of the World).
The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market is segmented by Product (PTCA balloon, PTCA guide), Application (OEMs, Aftermarket), and Region (North America, Europe, Asia-Pacific, and the Rest of the World)....
The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market is estimated to grow from USD xx million in 2020 to USD xx million by 2026 at a healthy CAGR of 3.6% during the forecast period.
The increasing geriatric population, as well as lifestyle changes, leads to obesity, hypertension, hypertension, high blood pressure, and high level of cholesterol in the blood. Moreover, the growing prevalence of cardiovascular disease is likely to propel the growth of the percutaneous transluminal coronary angioplasty products market. In addition, the launch of advanced products and reclassification of some PTCA catheters from class III to class II devices by the FDA further augments the product demand.
COVID-19 Impact
The COVID-19 outbreak positively influenced the growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. Senior adults and people suffering from cardiovascular diseases were at higher risk of getting infected, which, in turn, boosted the demand for PTCA products.
What is percutaneous transluminal coronary angioplasty?
Percutaneous transluminal coronary angioplasty could be a minimally invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). Coronary heart diseases are primarily caused by smoking, resulting in an unhealthy lifestyle, high pressure level, diabetes, and a high level of cholesterol within the blood.
Key Players
Key players operating in the Percutaneous Transluminal Coronary Angioplasty (PTCA) products market are-
Abbott Laboratories (US)
Terumo (Japan)
Boston Scientific (US)
Intact Vascular (US)
Asahi Intecc (Japan)
Angioscore (US)
Bard PV (US)
Cook Medical (US)
Cordis (US)
Medtronic (US).
Segment Analysis
Product Trends
The product, the market has been bifurcated into PTCA balloon and PTCA guide. The infectious diseases segment accounted for a substantial market share in 2020. This is mainly attributed to rising cases of cardiovascular diseases across the globe. Also, the PTCA balloon is easy to use and safe. In addition, the cost associated with the PTCA balloon is relatively low, is likely to segment growth in the coming years.
Regional Analysis
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to enhanced healthcare infrastructure coupled with several government initiatives. The growing incidences of cardiac disorders have further led to a surge in the demand for percutaneous transluminal coronary angioplasty products. A well-established healthcare system and high per capita healthcare expenditure are further augmenting up the growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market in the region.
Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-
Distributors
Suppliers
Manufacturers
Logistics organizations
Government bodies
Report Features
This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
How lucrative is the future?
Market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional and country level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Customization Options
Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].
Share Your CommentEnter your contact details so our analysts can reach out to you
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
Published reports are typically delivered within 24 hours.
If the dataset is ready but the report is still being prepared, the dataset is usually delivered within 24 hours, while the completed report is delivered within 2 weeks.
For ongoing studies, both the dataset and the final report are generally delivered within 4–5 weeks .
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
Abbott Laboratories (US), Terumo (Japan), Boston Scientific (US), Intact Vascular (US), Asahi Intecc (Japan), Angioscore (US), Bard PV (US), Cook Medical (US), Cordis (US), and Medtronic (US) are among the key player in the market.
The increasing geriatric population, as well as lifestyle changes, growing prevalence of cardiovascular disease are the factors driving the growth of percutaneous transluminal coronary angioplasty products market.
